Litigation Details for UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. (D.N.J. 2015)

UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. (D.N.J. 2015)

Docket		Date Filed	2015-07-22
Court	District Court, D. New Jersey	Date Terminated	2018-09-18
Cause	35:271 Patent Infringement	Assigned To	Peter G. Sheridan
Jury Demand	None	Referred To	Lois H. Goodman
Parties	WATSON LABORATORIES, INC.
Patents	6,521,212; 6,756,033; 8,497,393; 9,339,507; 9,358,240
Attorneys	JOSEPH L. LINARES; LIZA M. WALSH
Firms	McCarter and English, LLP
Link to Docket	External link to docket

Details for UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. (D.N.J. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-07-27	130		Hatch-Waxman patent case involving five patents: U.S. Patent Nos. 6,521,212 (“the ’212 patent”), 6,756,033…,033 (“the ’033 patent”), 8,497,393 (“the ’393 patent”), 9,339,507 (“the ’507 patent”), and 9,358,240… the patents-in-suit, the ‘393 patent, was determined to be invalid by the United States Patent and Trial…2017. Two additional patents-in-suit, the ‘507 and ‘240 patents, are currently the subject of…resolution of two recently-filed IPRs on two of the patents-in-suit. If the stipulation and proposed order	External link to document
2018-01-15	137		Hatch-Waxman patent case involving five patents: U.S. Patent Nos. 6,521,212 (“the ’212 patent”), 6,756,033…,033 (“the ’033 patent”), 8,497,393 (“the ’393 patent”), 9,339,507 (“the ’507 patent”), and 9,358,240… the patents-in-suit, the ‘393 patent, was determined to be invalid by the United States Patent and Trial…certiorari. Two additional patents-in-suit, the ‘507 and ‘240 patents, are currently the subject of… 2019. The final two patents-in-suit, the ‘212 and ‘033 patents, are set to expire on November	External link to document